This is your first post on the ATH thread. Thank you for your opinion However you are totally wrong The CEO DS has mentioned many times in the past Webinars that he is in consult with many Partners( big Pharma) DS has been successful in bringing 3 drugs to commercialisation.$$ I was in PER for 15 years so I know what the CEO was doing to prepare if the drug was successful.. but the drug failed… 1) get institutional Investors on our register 2) Have $$ in the bank for better negotiating power 3)Have Partners lined up post results 4) Experienced staff to handle commercialisation 4) Experienced staff to handle negotiations with FDA and Partner.
Ath has done all these above . But here’s the thing ATH have STELLA results Phase 2.. and have conducted their phase 2 with PLACEBO.. Something PER failed to do. Went from a Pilot study to a Phase 3… and failed…
Yes you can wait for the green light from the FDA and a Partner… like picking the whole field at the races for a win…
If we get AA from the FDA and a big Pharma as a Partner..
refer to my previous post re $51 million is going to be used for..Anyway if you want to pay above 10c per share in the future it’s your call.. All these Institutions have coughed up $46 million..have done thorough DD on ATH.. The 12 month study 434/2 will show better results out this 1/4 I think …
ATH Price at posting:
1.2¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)